Corporate Development MBA Intern, M&A
Our mission is to make biology easier to engineer. Ginkgo is constructing, editing, and redesigning the living world in order to answer the globe’s growing challenges in health, energy, food, materials, and more. Our bioengineers make use of an in-house automated foundry for designing and building new organisms.
Ginkgo recently raised $1.6B and a major use of proceeds is a much more proactive Mergers and Acquisitions (M&A) strategy. The Corporate Development team at Ginkgo is a small, fast-paced, high-performing group responsible for sourcing, evaluating, negotiating and executing M&A transactions and investments. This team is central to Ginkgo’s continued growth. We work closely with senior leadership to guide company strategy and lead all aspects of identifying, evaluating, and executing transactions that have a significant impact on the overall direction of the company.
As a Corporate Development Intern, you will help the team landscape and identify interesting and worthwhile areas for Mergers and Acquisitions (M&A), and specific opportunities that accelerate or increase the likelihood of Ginkgo achieving its strategic objectives. You will report to the Vice President of Corporate Development. Additionally, you’ll work with cross-functional teams to conduct buy vs. build analysis, and help develop prioritized target lists and a streamlined process around M&A target filtering.
The Ginkgo Bioworks Early Talent program is open to students who will return to their degree programs upon completion of their employment at Ginkgo. Candidates must be enrolled in a United States based institution and/or have work authorization in the United States to be eligible to participate.
Responsibilities
- Identify and recommend companies and technologies for Ginkgo to consider for M&A. This will entail conducting landscapes, and developing strategies around the landscapes and recommendations as well as conduct build vs. buy analysis
- Help refine the processes and analytical frameworks for evaluating and executing M&A opportunities and investments
- Help standardize the M&A process at Ginkgo further, including potentially standardized modeling templates among other things
Minimum Requirements
- Current enrollment in an MBA degree program
- 3+ years of relevant M&A deal-making experience, whether in investment banking, corporate development, private equity, venture capital, management consulting or otherwise
- Demonstrated experience supporting work on sourcing, evaluating, and executing successful M&A deals.
- Ability to work effectively with cross-functional senior executives in a fast-paced and ambiguous environment
- Proficient in financial modeling, valuation, and broad quantitative analysis with a familiarity of basic accounting principles
Preferred Capabilities and Experience
- Prior experience within a startup or fast-paced environment
- Ideally you have work experience and knowledge of the life sciences industry and/or biotech. If you have working knowledge of the synthetic biology industry, even better!
We also feel that it’s important to point out the obvious here – there’s a serious lack of diversity in our industry, and that needs to change. Our goal is to help drive that change. Ginkgo is deeply committed to diversity, equity, and inclusion in all of its practices, especially when it comes to growing our team. Our culture promotes inclusion and embraces how rewarding it is to work with people from all walks of life.
We’re developing a powerful biological engineering platform, so we must remain mindful of the many ways our technology can – and will – impact people around the world. We care about how our platform is used, and having a diverse team to build it gives us the best chance that it’s something we’ll be proud of as it continues to grow. Therefore, it’s critical that we incorporate the diverse voices and visions of all those who play a role in the future of biology.
It is the policy of Ginkgo Bioworks to provide equal employment opportunities to all employees and employment applicants.